The largest database of trusted experimental protocols

Beh300 c18

Manufactured by Waters Corporation
Sourced in United States

The BEH300 C18 is a chromatography column designed for high-performance liquid chromatography (HPLC) and ultra-high-performance liquid chromatography (UHPLC) applications. It features a 1.7 μm particle size and a 300 Å pore size, which provide efficient separation and high-resolution analysis of a wide range of analytes.

Automatically generated - may contain errors

5 protocols using beh300 c18

1

Cross-Linked Peptides Analyzed by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Between 2 and 10% of the collected fractions were analysed by LC–MS/MS using a nanoAcquity UPLC system (Waters Corporation, Manchester, UK) connected online to an LTQ-Orbitrap Velos Pro instrument (Thermo). Peptides were separated on a BEH300 C18 (75 μm × 250 mm, 1.7 μm) nanoAcquity UPLC column (Waters) using a stepwise 60 min gradient between 3 and 85% (v/v) ACN in 0.1% (v/v) FA. Data acquisition was performed using a TOP-20 strategy where survey MS scans (m/z range 375–1,600) were acquired in the Orbitrap (R=30,000) and up to 20 of the most abundant ions per full scan were fragmented by collision-induced dissociation (normalized collision energy=40, activation Q=0.250) and analysed in the LTQ Orbitrap. To focus the acquisition on larger cross-linked peptides, charge states 1, 2 and unknown were rejected. Dynamic exclusion was enabled with repeat count=1, exclusion duration=60 s, list size=500 and mass window ±15 p.p.m. Ion target values were 1,000,000 (or 500 ms maximum fill time) for full scans and 10,000 (or 50 ms maximum fill time) for MS/MS scans. All the samples were analysed in at least technical duplicates.
+ Open protocol
+ Expand
2

Tryptic Peptide Separation and Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tryptic peptides (20 µg) were separated using an Agilent 1200 HPLC with a Waters BEH300 C18 (1.7 µm, 2.1×150 mm) column. Peptide elution was performed using a gradient from 100% solvent A (water, 0.1% trifluoroacetic acid) to 55% solvent B (acetonitrile, 0.08% trifluoroacetic acid) over 45 min at a flow rate of 0.3 mL/min and column temperature of 77 °C. Samples were analyzed on an Orbitrap Elite (Thermo Fisher, Bremen Germany). A full mass scan in the positive-ion mode (60,000 mass resolving power at m/z 400 from m/z 400-2000) was performed using the Orbitrap analyzer. Data-dependent acquisition (DDA) MS2 analysis was performed in the ion trap (IT) analyzer for the product-ion analysis of the six most abundant ions.
+ Open protocol
+ Expand
3

Peptide Separation and Analysis by nanoUPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptides were separated with a BEH300 C18 (75 μm x 250 mm, 1.7 μm) nanoAcquity UPLC column (Waters) using a stepwise 145 min gradient from 3% to 85% (v/v) acetonitrile in 0.1% (v/v) formic acid at a flow rate of 300 nl/min. The LTQ-Orbitrap Velos Pro instrument was operated in data-dependent mode. Parameters for the CID-based method used one survey MS scan acquired in the orbitrap followed by up to 20 fragmentation scans (TOP20) of the most abundant ions analysed in the LTQ. Only charge states of two and higher were allowed for fragmentation. Essential MS settings were: full MS: AGC = 106, maximum ion time = 500 ms, m/z range = 375–1600, resolution = 30 000 FWHM; MS2: AGC = 30 000, maximum ion time = 50 ms, minimum signal threshold = 1500, dynamic exclusion time = 30 s, isolation width = 2 Da, normalized collision energy = 40, activation Q = 0.25.
+ Open protocol
+ Expand
4

High-throughput Peptide Separation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 10 fractions obtained by high pH fractionation were analyzed using a nanoAcquity UPLC system (Waters GmbH) connected online to a LTQ-Orbitrap Velos Pro instrument (Thermo Fisher Scientific GmbH). Peptides were separated on a BEH300 C18 (75 μm × 250 mm, 1.7 μm) nanoAcquity UPLC column (Waters GmbH) using a stepwise 145 min gradient between 3% and 85% (vol/vol) ACN in 0.1% (vol/vol) FA. Data acquisition was performed using a TOP-20 strategy where survey MS scans (m/z range 375–1,600) were acquired in the Orbitrap (R = 30,000 FWHM) and up to 20 of the most abundant ions per full scan were fragmented by collision-induced dissociation (normalized collision energy = 35, activation Q = 0.250) and analyzed in the LTQ. Ion target values were 1 × 106 (or 500 ms maximum fill time) for full scans and 1 × 105 (or 50 ms maximum fill time) for MS/MS scans. Charge states 1 and unknown were rejected. Dynamic exclusion was enabled with repeat count = 1, exclusion duration = 60 s, list size = 500 and mass window ±15 ppm.
+ Open protocol
+ Expand
5

Peptide Identification via ESI-TOF-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
ESI-TOF-MS was used for the identification of peptides from HPLC Fractions as described by Dang et al. (15 (link)). Electrospray ionization (ESI) was used in positive ion mode, source temperature was set at 150°C, desolvation temperature was set at 550°C, scan range was m/z 50–1200. The most active fraction (F6) was resuspended in water at a concentration of 1 mg/mL. The filtrate was then analyzed with the ESI-TOF mass spectrometer of the ACQUITY UPLC H-Class HPLC system (Waters, USA). The column used was BEH300 C18 (2.1 × 100 mm; 1.7 μm) (Waters, USA), the flow rate was 0.2 mL/min, and the injection volume was 10 μL. All MS and MS/MS spectra were collected and analyzed using Mass Lynx (Waters version 4.1). The PepSeq program of Biolynx (Waters Corp.) software was used for sequencing. These peptides were custom-synthesized by Sangon Biotech Co., Ltd., (Shanghai, China) (16 ).
The purity of these peptides was above 99%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!